Sun Woo Kim
- Nephrology top 2%
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Diabetes Treatment and Management 5
- Epidemiology top 5%
- Adipokines, Inflammation, and Metabolic Diseases 6
- Liver Disease Diagnosis and Treatment 6
-
- Peroxisome Proliferator-Activated Receptors 4
- Metabolism, Diabetes, and Cancer 4
-
- Adipose Tissue and Metabolism 4
-
- Bone health and treatments 3
- Co-authors
- Won‐Young LeeEun‐Jung RheeKi Won OhCheol‐Young ParkSe Eun ParkHyang KimJi Cheol BaeMan Ho Lee
- Journals
- PLoS ONE (2 papers)The Journal of Clinical Endocrinology & Metabolism (1 paper)Diabetes Care (1 paper)
- Partner nations
- South Korea
In The Last Decade
Sun Woo Kim
35 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 105
- Nephrology 326
- Endocrinology, Diabetes and Metabolism 579
- Epidemiology 657
- Pathology and Forensic Medicine 285
- Orthopedics and Sports Medicine 136
Countries citing papers authored by Sun Woo Kim
This map shows the geographic impact of Sun Woo Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sun Woo Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sun Woo Kim more than expected).
Fields of papers citing papers by Sun Woo Kim
This network shows the impact of papers produced by Sun Woo Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sun Woo Kim. The network helps show where Sun Woo Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sun Woo Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2020 | 3 | |
| 3 | 2017 | 20 | |
| 4 | 2012 | 143 | |
| 5 | 2011 | 20 | |
| 6 | 2011 | 18 | |
| 7 | 2011 | 72 | |
| 8 | 2011 | 8 | |
| 9 | 2010 | 37 | |
| 10 | 2009 | 11 | |
| 11 | 2009 | 20 | |
| 12 | 2008 | 64 | |
| 13 | 2006 | 60 | |
| 14 | 2006 | 23 | |
| 15 | 2005 | 59 | |
| 16 | 2005 | 325 | |
| 17 | 2004 | 170 | |
| 18 | 2004 | 10 | |
| 19 | 2004 | 57 | |
| 20 | 2003 | 67 |
About Sun Woo Kim
Sun Woo Kim is a scholar working on Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine and Physiology, having authored 38 papers that have together received 1.5k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Diabetes Treatment and Management (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Adipose Tissue and Metabolism (4 papers) and Bone health and treatments (3 papers). The work is most often cited by research in Nephrology (326 citations), Endocrinology, Diabetes and Metabolism (579 citations) and Epidemiology (657 citations). Sun Woo Kim has collaborated with scholars based in South Korea. Frequent co-authors include Won‐Young Lee, Eun‐Jung Rhee, Ki Won Oh, Cheol‐Young Park, Se Eun Park, Hyang Kim, Ji Cheol Bae, Man Ho Lee, Jin Ho Kang and Ki‐Chul Sung. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.